XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer

This study is currently recruiting participants.
Verified August 2011 by Epidemiological and Clinical Research Information Network
Sponsor:
Information provided by (Responsible Party):
Epidemiological and Clinical Research Information Network
ClinicalTrials.gov Identifier:
NCT01412294
First received: July 30, 2011
Last updated: September 22, 2013
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)